Wylei Inc., an AI Predictive Content technology and marketing automation pioneer, today announced the appointment of Denice Torres to its Board of Directors. Torres is a recent past President for J&J, and an industry thought leader, with a strong background in digital marketing and executive management.
“The addition of Denice to the Wylei board is a major milestone for the company. Denice is a well-known and award-winning industry veteran and experienced executive. Her industry knowledge, mentoring and reach will be invaluable to Wylei,” said Wylei CEO Meg Columbia-Walsh.
The Wylei board provides leadership for carrying out Wylei’s mission to promote growth and revenue by leveraging advanced AI and machine learning technology to drive true 1:1 marketing personalization at scale. Torres joins the ranks of acclaimed board members including Meg Columbia-Walsh, John Martinson, Kevin Mably and Sheryl Goldstein.
Torres is a senior executive with an extensive healthcare and consumer experience developed across a 25-year career at Johnson & Johnson and Eli Lilly. At J&J, Torres served as Chief Strategy and Business Transformation Officer for the medical device sector, Co-Chair of the North America Consumer Business, President of McNeil Consumer Healthcare, and President of Janssen Pharmaceuticals, CNS. Prior to J&J, Torres held senior commercialization roles with Lilly.
She has extensive experience in corporate and portfolio strategy and has managed all major business functions. Torres has a strong background in marketing and is passionate about exceeding customer expectations. In 2015, Torres was selected Woman of the Year by Healthcare Business Women’s Association.
Denice Torres has a BS in Psychology from Ball State, JD from Indiana University, and MBA from the University of Michigan.